相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Fanconi anemia, complementation group D2
- 亚型:
IgG
- 形态:
liquid
- 保存条件:
负20摄氏度
- 克隆性:
Polyclonal antibody
- 标记物:
Non-conjugated
- 适应物种:
Human
- 保质期:
6个月
- 抗原来源:
Rabbit
- 目录编号:
Q9WVH4
- 级别:
纯化级别
- 库存:
50
- 供应商:
LSM bio
- 宿主:
E. coli - derived recombinant protein
- 应用范围:
ELISA,WB,IHC
- 浓度:
≥95% as determined by SDS-PAGE
- 靶点:
FANCD2-phospho(S330)
- 抗体英文名:
anti-FANCD2-phospho(S330) antibody,FANCD2-phospho(S330) antibody
- 抗体名:
anti-FANCD2-phospho(S330) 抗体,FANCD2-phospho(S330) 抗体
- 规格:
100μl
FANCD2-phospho(S330)抗体| FANCD2-phospho(S330) antibody
货号 PAab03007
蛋白别名
蛋白介绍
产品描述
anti-FANCD2-phospho(S330) antibody is a Rabbit Polyclonal antibody againstFANCD2-phospho(S330)..
建议稀释比例
IHC
Immunohistochemistry of paraffin-embedded human testis using PAab03007(FANCD2-phospho antibody) at dilution of 1:50
Western blot
HL-60 cells were subjected to SDS PAGE followed by western blot with PAab03007(FANCD2-phospho antibody) at dilution of 1:200(本抗体仅供体外科研用途,不可用于临床诊断!)
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Optimized Protocol to Make Phospho-Specific Antibodies that Work
, not simply its level of expression. In this review, we will discuss both the design of the phosphopeptide immunogen and immunization. The affinity purification of the phospho-specific antibody as well as the methods most suitable for characterizing
Using Phospho‐Motif Antibodies to Determine Kinase Substrates
comprising both the phosphorylated residue and the surrounding residues that determine kinase specificity, with degenerate residues taking up the remaining positions. Currently, several categories of phospho?motif antibody are commercially available
Absorption Control in Immunohistochemistry Using Phospho-Peptides Immobilized on Magnetic Beads
neutralization of phospho-specific antibodies with phospho-peptides immobilized on magnetic beads. This technique allows for sequestration of antibody–peptide complex from the incubation solution, minimizing the risk of formation of unblocked antibodies capable
技术资料暂无技术资料 索取技术资料







